Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer (Protocol Number GK001)

NCT02568033 is registered in ClinicalTrials.gov with The Cooper Health System as lead sponsor.

NCT NCT02568033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02568033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer (Protocol Number GK001)
Lead sponsor
The Cooper Health System
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2013
Completion date
October 31, 2017
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer